Optimizing Gemcitabine Regimens in Ovarian Cancer-Reference-Cited by-同舟云学术

Optimizing Gemcitabine Regimens in Ovarian Cancer

Published:2006-04 Issue: Volume:33 Page:17-25
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Pecorelli Sergio,Pasinetti Brunella,Tisi Giancarlo,Odicino Franco

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference85 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Society for Gynecologic Oncologists: New directions in ovarian cancer research. Report of the Strategic Planning Conference, December 8–9, 1997. Available at: http://www3.cancer.gov/ovarian.pdf (accessed Feb 17, 2006)

3. Chemotherapy of ovarian cancer;Ozols;Semin Oncol,1991

4. Chemotherapy in advanced ovarian cancer – An overview of randomised clinical trials;BMJ,1991

5. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials;Young;N Engl J Med,1990

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in immunological and theranostic approaches of gold nanoparticles – A review;Inorganic Chemistry Communications;2023-07

2. A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer;Gynecologic Oncology Research and Practice;2017-11-14

3. Review on gold nanoparticles and their applications;Toxicology and Environmental Health Sciences;2011-12

4. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer;Advanced Drug Delivery Reviews;2010-03

5. Pegylated liposomal doxorubicin for relapsed ovarian cancer;Cochrane Database of Systematic Reviews;2008-01-23